Fig. 1.
Analysis strategy for identifying differentially expressed probes or enriched pathway-defined gene sets in the Nurses’ Health Study (NHS) and the NHSII. FDR false discovery rate, LIMMA linear models for microarray data
Analysis strategy for identifying differentially expressed probes or enriched pathway-defined gene sets in the Nurses’ Health Study (NHS) and the NHSII. FDR false discovery rate, LIMMA linear models for microarray data